APOE and Alzheimer disease: In addition, agonists of Liver X receptors (LXR), which act as cholesterol sensors and promote lipidation of APOE by ATP-binding cassette transporter A1 (ABCA1), ameliorate neuronal injury in experimental models of trauma [58] and reverse deficits in mouse models of AD [59].